ODM-207

CAS No. 1801503-93-4

ODM-207( BET-IN-4 | ODM-207 | ODM207 )

Catalog No. M26070 CAS No. 1801503-93-4

BET-IN-4 is a potent BRD4 inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 92 In Stock
5MG 84 In Stock
10MG 136 In Stock
25MG 249 In Stock
50MG 351 In Stock
100MG 496 In Stock
200MG 682 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    ODM-207
  • Note
    Research use only, not for human use.
  • Brief Description
    BET-IN-4 is a potent BRD4 inhibitor.
  • Description
    BET-IN-4 is a potent BRD4 inhibitor.(In Vitro):BET-IN-4 inhibits BRD4 with an IC50 of ≤ 1 μM.
  • In Vitro
    ODM-207 (Compound 50) is a potent BET bromodomain protein (BRD4) inhibitor, with an IC50 of ≤ 1 μM.
  • In Vivo
    ——
  • Synonyms
    BET-IN-4 | ODM-207 | ODM207
  • Pathway
    Chromatin/Epigenetic
  • Target
    Epigenetic Reader Domain
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1801503-93-4
  • Formula Weight
    375.428
  • Molecular Formula
    C22H21N3O3
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 10 mg/mL (26.64 mM)
  • SMILES
    COc1cc2n(Cc3ccccn3)c(=O)c(C)cc2cc1-c1c(C)noc1C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Kao-Lu Pan, et al. Identification of trans,trans-2,4-decadienal metabolites in mouse and human cells using liquid chromatography-mass spectrometry. Chem Res Toxicol. 2014 Oct 20;27(10):1707-19.
molnova catalog
related products
  • SR-0813

    SR-0813 is a potent and selective inhibitor of the YEATS domain in ENL/AF9, with an IC50 of 25 nM and EC50 of 205 nM for the ENL YEATS domain, and an IC50 of 311 nM and EC50 of 76 nM (CETSA) for the AF9 YEATS domain.

  • Oxyphencyclimine Hyd...

    Oxyphencyclimine Hydrochloride is a synthetic tertiary amine and antimuscarinic agent with antispasmodic and antisecretory activities.

  • BRD7-IN-1

    BRD7-IN-1, a modified derivative of BI7273 (BRD7/9 inhibitor), forms PROTAC VZ185 via linkage to a VHL ligand, demonstrating potent activity against BRD7/9 with DC50 values of 4.5 and 1.8 nM, respectively .